Helix Acquisition Corp. II

Ownership Transactions Reported by 18 Insiders

Symbol
HLXB on Nasdaq
Industry
Pharmaceutical Preparations
Location
C/O Cormorant Asset Management, Lp, 200 Clarendon Street, 52 Nd Floor, Boston, MA

There are no Buy or Sell transactions made by insiders since 12/5/2024

Helix Acquisition Corp. II executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bihua Chen Director, 10%+ Owner $192M Aug 11, 2025
BridgeBio Pharma LLC 10%+ Owner $167M Oct 10, 2025
Mark C. McKenna Former Director $322K Aug 11, 2025
John P. Schmid Former Director $322K Aug 11, 2025
Albert A. Holman III Former Director $322K Aug 11, 2025
Eli M. Wallace Chief Executive Officer, Director Oct 2, 2025
Praveen P. Tipirneni Director Aug 26, 2025
Michelle Doig Director Aug 11, 2025
Pedro Beltran Chief Scientific Officer Aug 26, 2025
Uneek Mehra Chief Financial Officer Aug 26, 2025
Yong Ben Chief Med & Dev Officer Aug 26, 2025
Raymond J. Kelleher Director Aug 11, 2025
Nebojsa Obradovic Chief Legal Officer Aug 11, 2025
Caleb Tripp Chief Financial Officer Aug 11, 2025
Frank Mccormick Director Aug 26, 2025
Jake Bauer Director Aug 26, 2025
Neil Kumar Director Aug 11, 2025
Helix Holdings II LLC Director, 10%+ Owner Feb 8, 2025

Recent Insider Transactions by Companies or Individuals for Helix Acquisition Corp. II

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.